OVID THERAPEUTICS INC (OVID) Institutional Ownership Changes & 13F Activity

OVID THERAPEUTICS INC (OVID). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Braidwell Lp, Saturn V Capital Management Lp, Adar1 Capital Management, Llc, Stempoint Capital Lp, and Ally Bridge Group (Ny) Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Manufacturers Life Insurance Company, TheBuy+40,91040,910$110.05KQ2 2026Sep 09, 2026
California State Teachers Retirement SystemBuy+2,1092,109$5.67KQ2 2026Aug 24, 2026
Assenagon Asset Management S.A.Sell-210,198-92.3%17,544$47.19KQ2 2026Aug 21, 2026
Stonepine Capital Management, LlcSell-18,700-46.8%21,300$57.30KQ2 2026Aug 17, 2026
Braidwell LpBuy+5,919,4645,919,464$15.92MQ2 2026Aug 14, 2026
Saturn V Capital Management LpSell-3,503,606-84.1%663,060$1.78MQ2 2026Aug 14, 2026
Adar1 Capital Management, LlcBuy+2,873,366+63.2%7,417,479$19.95MQ2 2026Aug 14, 2026
Stempoint Capital LpBuy+2,417,2832,417,283$6.50MQ2 2026Aug 14, 2026
Ally Bridge Group (Ny) LlcSell-2,193,898-77.8%624,561$1.68MQ2 2026Aug 14, 2026
Eventide Asset Management, LlcBuy+1,895,330+19.1%11,812,241$31.77MQ2 2026Aug 14, 2026
Susquehanna International Group, LlpSell-1,876,994-96.4%70,600$189.91KQ2 2026Aug 14, 2026
Millennium Management LlcSell-1,464,223-97.8%32,295$86.87KQ2 2026Aug 14, 2026
Balyasny Asset Management L.P.Buy+1,186,003+21.4%6,719,076$18.07MQ2 2026Aug 14, 2026
Ensign Peak Advisors, IncBuy+988,084988,084$2.66MQ2 2026Aug 14, 2026
Orbimed Advisors LlcBuy+747,000747,000$2.01MQ2 2026Aug 14, 2026
Point72 Asset Management, L.P.Buy+625,117+47.3%1,945,727$5.23MQ2 2026Aug 14, 2026
Ikarian Capital, LlcSell-625,000-21.6%2,269,704$6.11MQ2 2026Aug 14, 2026
Two Sigma Investments, LpSell-424,491-33.8%832,378$2.24MQ2 2026Aug 14, 2026
Charles Schwab Investment Management IncBuy+372,042+516.7%444,042$1.19MQ2 2026Aug 14, 2026
Sphera Funds Management Ltd.Sell-269,828-16.6%1,353,000$3.64MQ2 2026Aug 14, 2026
Atom Investors LpBuy+251,836251,836$677.44KQ2 2026Aug 14, 2026
Sio Capital Management, LlcSell-247,047-19.7%1,005,334$2.70MQ2 2026Aug 14, 2026
Ra Capital Management, L.P.Sell-213,032-2.0%10,500,968$28.25MQ2 2026Aug 14, 2026
Boothbay Fund Management, LlcSell-190,155-20.5%737,758$1.98MQ2 2026Aug 14, 2026
Goldman Sachs Group IncBuy+179,845+117.7%332,692$894.94KQ2 2026Aug 14, 2026
Squarepoint Ops LlcSell-179,034-90.4%18,937$50.94KQ2 2026Aug 14, 2026
Schonfeld Strategic Advisors LlcSell-177,162-83.5%35,049$94.28KQ2 2026Aug 14, 2026
Invesco Ltd.Buy+174,900174,900$470.48KQ2 2026Aug 14, 2026
Rafferty Asset Management, LlcBuy+136,774136,774$367.92KQ2 2026Aug 14, 2026
Sei Investments CoSell-132,239-40.2%196,685$529.08KQ2 2026Aug 14, 2026
Showing 30 of 123

Frequently asked questions about OVID activity

  • Which institutional owners are buying OVID?

    Institutional owners buying OVID include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in OVID activity?

    "Buy" means an investor increased their reported position in OVID compared to the prior reporting period. This reflects growing exposure to OVID THERAPEUTICS INC (OVID) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in OVID increasing?

    Institutional interest in OVID can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.